241 related articles for article (PubMed ID: 16670715)
1. Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study.
Van den Eynden GG; Van der Auwera I; Van Laere SJ; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
Br J Cancer; 2006 Jun; 94(11):1643-9. PubMed ID: 16670715
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of detecting lymphatic and blood vessel invasion in stage II colon cancer using markers D2-40 and CD34 in combination.
Lai JH; Zhou YJ; Bin D; Qiangchen ; Wang SY
Asian Pac J Cancer Prev; 2014; 15(3):1363-7. PubMed ID: 24606466
[TBL] [Abstract][Full Text] [Related]
3. Assessment of vascular invasion in gastric cancer: a comparative study.
Gresta LT; Rodrigues-Júnior IA; de Castro LP; Cassali GD; Cabral MM
World J Gastroenterol; 2013 Jun; 19(24):3761-9. PubMed ID: 23840114
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of lymphatic and blood vessel invasion in operable breast cancer.
Lauria R; Perrone F; Carlomagno C; De Laurentiis M; Morabito A; Gallo C; Varriale E; Pettinato G; Panico L; Petrella G
Cancer; 1995 Nov; 76(10):1772-8. PubMed ID: 8625046
[TBL] [Abstract][Full Text] [Related]
5. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
[TBL] [Abstract][Full Text] [Related]
6. Tumor cell invasion in blood vessels assessed by immunohistochemistry is related to decreased survival in patients with bladder cancer treated with radical cystectomy.
Carlsen B; Klingen TA; Andreassen BK; Haug ES
Diagn Pathol; 2021 Nov; 16(1):109. PubMed ID: 34809660
[TBL] [Abstract][Full Text] [Related]
7. Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis.
Marinho VF; Metze K; Sanches FS; Rocha GF; Gobbi H
BMC Cancer; 2008 Feb; 8():64. PubMed ID: 18307818
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of lymphovascular invasion in carcinoma breast with CD34 and D2-40 and its correlation with other prognostic markers.
Agarwal S; Singh A; Bagga PK
Indian J Pathol Microbiol; 2018; 61(1):39-44. PubMed ID: 29567882
[TBL] [Abstract][Full Text] [Related]
9. Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up.
Mohammed RA; Martin SG; Mahmmod AM; Macmillan RD; Green AR; Paish EC; Ellis IO
J Pathol; 2011 Feb; 223(3):358-65. PubMed ID: 21171081
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of immunohistochemically detected blood and lymphatic vessel invasion in colorectal carcinoma: its impact on prognosis.
Liang P; Nakada I; Hong JW; Tabuchi T; Motohashi G; Takemura A; Nakachi T; Kasuga T; Tabuchi T
Ann Surg Oncol; 2007 Feb; 14(2):470-7. PubMed ID: 17103258
[TBL] [Abstract][Full Text] [Related]
11. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer.
Arnaout-Alkarain A; Kahn HJ; Narod SA; Sun PA; Marks AN
Mod Pathol; 2007 Feb; 20(2):183-91. PubMed ID: 17206106
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical assessment of lymphatic and blood vessel invasion in T1 urothelial carcinoma of the bladder.
Gakis G; Todenhöfer T; Braun M; Fend F; Stenzl A; Perner S
Scand J Urol; 2015; 49(5):382-7. PubMed ID: 25921278
[TBL] [Abstract][Full Text] [Related]
13. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma.
Sakuragi N; Takeda N; Hareyama H; Fujimoto T; Todo Y; Okamoto K; Takeda M; Wada Si; Yamamoto R; Fujimoto S
Cancer; 2000 Jun; 88(11):2578-83. PubMed ID: 10861436
[TBL] [Abstract][Full Text] [Related]
14. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival.
Bréchot JM; Chevret S; Charpentier MC; Appere de Vecchi C; Capron F; Prudent J; Rochemaure J; Chastang C
Cancer; 1996 Nov; 78(10):2111-8. PubMed ID: 8918404
[TBL] [Abstract][Full Text] [Related]
15. Detection of lymphovascular invasion in vulvar cancer by D2-40 (podoplanin) as a predictor for inguinal lymph node metastases.
Braun M; Wardelmann E; Debald M; Walgenbach-Bruenagel G; Höller T; Wolfgarten M; Sauerwald A; Rudlowski C; Büttner R; Kuhn W; Pölcher M
Onkologie; 2009 Dec; 32(12):732-8. PubMed ID: 20016234
[TBL] [Abstract][Full Text] [Related]
16. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.
Braun M; Flucke U; Debald M; Walgenbach-Bruenagel G; Walgenbach KJ; Höller T; Pölcher M; Wolfgarten M; Sauerwald A; Keyver-Paik M; Kühr M; Büttner R; Kuhn W
Breast Cancer Res Treat; 2008 Dec; 112(3):503-11. PubMed ID: 18165897
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Lymphatic Infiltration Detected by Immunohistochemical Double Staining in Patients with Endometrial Cancer.
Xu J; Wang X; Du Q; Qu P; Liu C
Clin Med Insights Oncol; 2023; 17():11795549231152308. PubMed ID: 36744170
[TBL] [Abstract][Full Text] [Related]
18. Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer.
Ito M; Moriya T; Ishida T; Usami S; Kasajima A; Sasano H; Ohuchi N
Breast Cancer; 2007; 14(4):381-7. PubMed ID: 17986803
[TBL] [Abstract][Full Text] [Related]
19. Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival.
Klingen TA; Chen Y; Stefansson IM; Knutsvik G; Collett K; Abrahamsen AL; Aase H; Aas H; Aas T; Wik E; Akslen LA
J Clin Pathol; 2017 Apr; 70(4):313-319. PubMed ID: 27612505
[TBL] [Abstract][Full Text] [Related]
20. The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer.
Gujam FJ; Going JJ; Edwards J; Mohammed ZM; McMillan DC
Crit Rev Oncol Hematol; 2014 Feb; 89(2):231-41. PubMed ID: 24075309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
